Genvoya and Gemfibrozil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Genvoya (cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate) and Gemfibrozil (gemfibrozil). Common drug interactions include anhedonia among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Genvoya and Gemfibrozil. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Genvoya?

Genvoya has active ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 13,538 Genvoya users. Check the latest studies of Genvoya.

What is Gemfibrozil?

Gemfibrozil has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 18,213 Gemfibrozil users. Check the latest studies of Gemfibrozil.

On Jul, 12, 2026

39 people who take Genvoya and Gemfibrozil together, and have interactions are studied.

Genvoya and Gemfibrozil drug interactions.

What are the common drug interactions of Genvoya and Gemfibrozil, by gender? *:

female:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone density decreased
Depression
Emotional distress
Muscle mass
Osteoporosis (bones weak and more likely to break)
Pain
Skeletal injury (bone and supporting muscle injury)
Multiple fractures

male:

Pain
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Gait disturbance
Mobility decreased (ability to move is reduced)
Bone loss
Dysstasia (difficulty in standing)
Multiple fractures
Osteonecrosis (death of bone)
Osteoporosis (bones weak and more likely to break)
Drug resistance (reduction in effectiveness of a drug)

What are the common drug interactions of Genvoya and Gemfibrozil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone density decreased
Emotional distress
Pain
Renal failure (kidney dysfunction)
Depression
Osteonecrosis (death of bone)
Bone loss
Fracture

40-49:

Bone density decreased
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chronic kidney disease
Emotional distress
Osteopenia (a condition where bone mineral density is lower than normal)
Pain
Blood creatinine increased
Bone loss
Decreased activity

50-59:

Pain
Osteopenia (a condition where bone mineral density is lower than normal)
Bone density decreased
Chronic kidney disease
Ankle fracture
Depression
Mobility decreased (ability to move is reduced)
Multiple fractures
Tibia fracture (fracture of lower leg bone)
Compression fracture (fracture due to pressure caused by injury)

60+:

Memory impairment
Nightmare (unpleasant dream)
Pain
Bone pain
Drug ineffective
Pyrexia (fever)
Viral load increased

What are the existing conditions these people have? *

Pain: 4 people, 10.26%
Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 3 people, 7.69%
Hypertriglyceridaemia (excess of triglycerides in the blood): 3 people, 7.69%
Quit Smoking: 2 people, 5.13%
Hypersensitivity: 2 people, 5.13%
Dyslipidaemia (abnormal amount of lipids): 2 people, 5.13%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Genvoya and Gemfibrozil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously